Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
23Mofang
company
About
23Mofang provides genetic testing services for Chinese people and conducts life data analysis business.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥100M
- Industries
- Analytics,Biotechnology,Genetics,Health Care,Health Diagnostics,Medical Device
- Founded date
- Mar 1, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
23Mofang provides genetic testing services for Chinese people and conducts life data analysis business. The company relies on the Internet + genetic testing to build a large database of life, with the mission of "data life, benefit everyone", and build a trustworthy technology enterprise.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥140M
23Mofang has raised a total of
¥140M
in funding over 2 rounds. Their latest funding was raised on
Mar 5, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 5, 2018 | Series B | ¥100M | 2 | — | — | Detail |
| Aug 4, 2017 | Series B | ¥40M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
23Mofang is funded by 2 investors.
Chengdu Deshang Qidian Equity Investment
and Yahui Precision Medicine Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Yahui Precision Medicine Fund
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
